TADALAFIL Side Effects

7019814-7 | Cardiac Failure
on Sep 16, 2010 Male patient from JAPAN , 63 years of age, weighting 132.3 lb, was diagnosed with pulmonary hypertension (What is pulmonary hypertension?), chronic obstructive pulmonary disease and was treated with Tadalafil (View Usage). Patient experienced the following unwanted or unexpected effects: cardiac failure. Tadalafil dosage: 40 Mg, Daily (1/d). During the same period patient was treated with SPIRIVA (1d/f, Daily (1/d), Received Before Start Of Tadalafil) (View Spiriva Review and Spiriva Label ), SEREVENT (Two Aspiration, Daily (1/d), Received Before Start Of Tadalafil) (View Serevent Review and Serevent Label ), ALVESCO (400 Ug, Daily (1/d), Received Before Start Of Tadalafil) (View Alvesco Review and Alvesco Label ).

6974891-4 |
Patient was taking Tadalafil (View Usage). on Sep 03, 2010 from JAPAN Additional patient health information: Male patient , 49 years of age, weighting 138.9 lb, was diagnosed with pulmonary arterial hypertension, atrial fibrillation (What is atrial fibrillation?), constipation (What is constipation?), insomnia and. Tadalafil dosage: 40 Mg, Daily (1/d). During the same period patient was treated with LASIX (20 Mg, Daily (1/d)) (View Lasix Review and Lasix Label ), ALDACTONE (50 Mg, Daily (1/d)) (View Aldactone Review and Aldactone Label ), ARTIST (10 Mg, Daily (1/d)) (View Artist Review and Artist Label ), WARFARIN (3 Mg, Daily (1/d)) (View Warfarin Review and Warfarin Label ), PROTECADIN /JPN/ (10 Mg, Daily (1/d)) (View Protecadin /jpn/ Review and Protecadin /jpn/ Label ), NEUQUINON (30 Mg, Daily (1/d)) (View Neuquinon Review and Neuquinon Label ), MAGMITT (0.99 G, Daily (1/d)) (View Magmitt Review and Magmitt Label ), BENZALIN (5 Mg, Daily (1/d)) (View Benzalin Review and Benzalin Label ).

6970009-2 | Cerebral Ischaemia, Tachycardia
Adverse event was reported on Aug 30, 2010 by a Male patient taking Tadalafil (View Usage) (Dosage: 20 Mg, Unk) was diagnosed with erectile dysfunction (What is erectile dysfunction?) and. Location: LEBANON , 70 years of age, After Tadalafil was administered, patient had the following side effects: cerebral ischaemia, tachycardia. Patient was hospitalized.

6968170-9 | Pulmonary Oedema
on Aug 31, 2010 Female patient from JAPAN , 82 years of age, weighting 115.3 lb, was diagnosed with pulmonary arterial hypertension, pulmonary hypertension (What is pulmonary hypertension?), prophylaxis and was treated with Tadalafil (View Usage). Patient experienced the following unwanted or unexpected effects: pulmonary oedema. Tadalafil dosage: 20 Mg, Daily (1/d). During the same period patient was treated with TRACLEER (250 Mg, Daily (1/d)) (View Tracleer Review and Tracleer Label ), ACTONEL (2.5 Mg, Daily (1/d)) (View Actonel Review and Actonel Label ), WARFARIN SODIUM (1.5 Mg, Daily (1/d)) (View Warfarin Sodium Review and Warfarin Sodium Label ), THYRADIN S (50 Ug, Daily (1/d)) (View Thyradin S Review and Thyradin S Label ), MUCOSTA (View Mucosta Review and Mucosta Label ), MAGNESIUM OXIDE (View Magnesium Oxide Review and Magnesium Oxide Label ), TAKEPRON (View Takepron Review and Takepron Label ). Patient was hospitalized.


6961646-X | Pulmonary Oedema
on Aug 26, 2010 Female patient from JAPAN , 82 years of age, was treated with Tadalafil (View Usage). Patient had the following side effects: pulmonary oedema. Tadalafil dosage: 20 Mg, Daily (1/d). During the same period patient was treated with TRACLEER (250 Mg, Daily (1/d)) (View Tracleer Review and Tracleer Label ), ACTONEL (2.5 Mg, Daily (1/d)) (View Actonel Review and Actonel Label ), WARFARIN SODIUM (1 Mg, Daily (1/d)) (View Warfarin Sodium Review and Warfarin Sodium Label ), THYRADIN S (50 Ug, Daily (1/d)) (View Thyradin S Review and Thyradin S Label ), MUCOSTA (View Mucosta Review and Mucosta Label ), MAGNESIUM OXIDE (View Magnesium Oxide Review and Magnesium Oxide Label ), TAKEPRON (View Takepron Review and Takepron Label ). Patient was hospitalized.

6955360-4 | Angioedema, Headache, Nasal Congestion
Patient was taking Tadalafil (View Usage). After Tadalafil was administered, patient had the following side effects: angioedema, headache (What is headache?), nasal congestion on Aug 17, 2010 from INDIA Additional patient health information: Male patient , 30 years of age, was diagnosed with erectile dysfunction (What is erectile dysfunction?) and. Tadalafil dosage: 10 Mg, Daily (1/d).

6927194-8 | Hepatitis Cholestatic
Adverse event was reported on Aug 04, 2010 by a Male patient taking Tadalafil (View Usage) (Dosage: ) . Location: FRANCE , 38 years of age, Patient experienced the following unwanted or unexpected effects: hepatitis cholestatic.

6925868-6 | Pulmonary Oedema
on Aug 02, 2010 Female patient from JAPAN , 82 years of age, was treated with Tadalafil (View Usage). Patient had the following side effects: pulmonary oedema. Tadalafil dosage: 20 Mg, Daily (1/d). During the same period patient was treated with TRACLEER (250 Mg, Daily (1/d)) (View Tracleer Review and Tracleer Label ), ACTONEL (2.5 Mg, Daily (1/d)) (View Actonel Review and Actonel Label ), WARFARIN (1 Mg, Daily (1/d)) (View Warfarin Review and Warfarin Label ), THYRADIN S (50 Ug, Daily (1/d)) (View Thyradin S Review and Thyradin S Label ), MUCOSTA (View Mucosta Review and Mucosta Label ), MAGNESIUM OXIDE (View Magnesium Oxide Review and Magnesium Oxide Label ), TAKEPRON (View Takepron Review and Takepron Label ). Patient was hospitalized.

6894405-7 | Pulmonary Oedema
on Jul 22, 2010 Female patient from JAPAN , 82 years of age, was treated with Tadalafil (View Usage). After Tadalafil was administered, patient had the following side effects: pulmonary oedema. Tadalafil dosage: 20 Mg, Daily (1/d). During the same period patient was treated with TRACLEER (View Tracleer Review and Tracleer Label ). Patient was hospitalized.

6817568-8 | Arrhythmia, Tachycardia
Patient was taking Tadalafil (View Usage). Patient experienced the following unwanted or unexpected effects: arrhythmia (What is arrhythmia?), tachycardia on Jun 23, 2010 from FRANCE Additional patient health information: Male patient , weighting 165.3 lb, was diagnosed with pulmonary arterial hypertension, gastrooesophageal reflux disease, insomnia, hypokalaemia and. Tadalafil dosage: Unk, Daily (1/d). During the same period patient was treated with NEXIUM (View Nexium Review and Nexium Label ), PREVISCAN (View Previscan Review and Previscan Label ), BUFLOMEDIL (View Buflomedil Review and Buflomedil Label ), ATARAX (View Atarax Review and Atarax Label ), FUROSEMIDE (View Furosemide Review and Furosemide Label ), SPIRONOLACTONE (View Spironolactone Review and Spironolactone Label ), DIFFU K (View Diffu K Review and Diffu K Label ). Patient was hospitalized.

6816191-9 | Chest Pain, Interstitial Lung Disease, Tachycardia
Adverse event was reported on Jun 29, 2010 by a Male patient taking Tadalafil (View Usage) (Dosage: 40 Mg, Daily (1/d)) was diagnosed with pulmonary arterial hypertension, interstitial lung disease, prophylaxis and. Location: JAPAN , 64 years of age, weighting 137.6 lb, Patient had the following side effects: chest pain (What is chest pain?), interstitial lung disease, tachycardia. During the same period patient was treated with PREDNISOLONE (10 Mg, Daily (1/d)) (View Prednisolone Review and Prednisolone Label ), COTRIM (1 D/f, Daily (1/d)) (View Cotrim Review and Cotrim Label ), OMEPRAL (20 Mg, Daily (1/d)) (View Omepral Review and Omepral Label ), AMLODIPINE (5 Mg, Daily (1/d)) (View Amlodipine Review and Amlodipine Label ), BENET /JPN/ (17.5 Mg, Daily (1/d)) (View Benet /jpn/ Review and Benet /jpn/ Label ), MEDICON (90 Mg, Daily (1/d)) (View Medicon Review and Medicon Label ), CYCLOSPORINE (100 Mg, Daily (1/d)) (View Cyclosporine Review and Cyclosporine Label ), ITRIZOLE (20 Ml, Daily (1/d)) (View Itrizole Review and Itrizole Label ). Patient was hospitalized.

6813940-0 | Chronic Obstructive Pulmonary Disease
on Jun 28, 2010 Male patient from JAPAN , 65 years of age, weighting 177.5 lb, was diagnosed with pulmonary arterial hypertension and was treated with Tadalafil (View Usage). After Tadalafil was administered, patient had the following side effects: chronic obstructive pulmonary disease. Tadalafil dosage: 40 Mg, Daily (1/d). During the same period patient was treated with FLUITRAN (View Fluitran Review and Fluitran Label ), FUROSEMIDE (20 Mg, Daily (1/d)) (View Furosemide Review and Furosemide Label ).

6806834-8 | Balance Disorder, Chest Pain, Dyspnoea, Eructation, Headache, Hypoaesthesia, Musculoskeletal Stiffness, Nausea, Suprapubic Pain
on Jun 16, 2010 Male patient from UNITED KINGDOM , 76 years of age, weighting 167.6 lb, was diagnosed with erectile dysfunction (What is erectile dysfunction?), intracranial pressure increased, hypertension, constipation (What is constipation?) and was treated with Tadalafil (View Usage). Patient experienced the following unwanted or unexpected effects: balance disorder, chest pain (What is chest pain?), dyspnoea, eructation, headache (What is headache?), hypoaesthesia, musculoskeletal stiffness, nausea (What is nausea?), suprapubic pain. Tadalafil dosage: . During the same period patient was treated with ACETAZOLAM (125 Mg, 2/d) (View Acetazolam Review and Acetazolam Label ), BISOPROLOL FUMARATE (View Bisoprolol Fumarate Review and Bisoprolol Fumarate Label ), FYBOGEL (View Fybogel Review and Fybogel Label ), IRBESARTAN (View Irbesartan Review and Irbesartan Label ). Patient was hospitalized.

6779086-5 | Chest Pain, Interstitial Lung Disease, Tachycardia
Patient was taking Tadalafil (View Usage). Patient had the following side effects: chest pain (What is chest pain?), interstitial lung disease, tachycardia on Jun 11, 2010 from JAPAN Additional patient health information: Male patient , 64 years of age, weighting 137.6 lb, was diagnosed with pulmonary arterial hypertension, interstitial lung disease, prophylaxis and. Tadalafil dosage: 40 Mg, Daily (1/d). During the same period patient was treated with PREDNISOLONE (10 Mg, Daily (1/d)) (View Prednisolone Review and Prednisolone Label ), COTRIM (1 D/f, Daily (1/d)) (View Cotrim Review and Cotrim Label ), OMEPRAL (20 Mg, Daily (1/d)) (View Omepral Review and Omepral Label ), AMLODIPINE (5 Mg, Daily (1/d)) (View Amlodipine Review and Amlodipine Label ), BENET /JPN/ (17.5 Mg, Daily (1/d)) (View Benet /jpn/ Review and Benet /jpn/ Label ), MEDICON (90 Mg, Daily (1/d)) (View Medicon Review and Medicon Label ), CYCLOSPORINE (100 Mg, Daily (1/d)) (View Cyclosporine Review and Cyclosporine Label ), ITRIZOLE (20 Ml, Daily (1/d)) (View Itrizole Review and Itrizole Label ). Patient was hospitalized.

6761992-9 | Cardiac Failure, Pneumonia
Adverse event was reported on Jun 03, 2010 by a Male patient taking Tadalafil (View Usage) (Dosage: ) was diagnosed with pulmonary hypertension (What is pulmonary hypertension?) and. Location: JAPAN , 45 years of age, After Tadalafil was administered, patient had the following side effects: cardiac failure, pneumonia (What is pneumonia?).

6704387-6 | Pulmonary Arterial Hypertension
on Apr 26, 2010 Male patient from JAPAN , 64 years of age, weighting 137.6 lb, was diagnosed with pulmonary arterial hypertension, interstitial lung disease, prophylaxis and was treated with Tadalafil (View Usage). Patient experienced the following unwanted or unexpected effects: pulmonary arterial hypertension. Tadalafil dosage: 40 Mg, Daily (1/d). During the same period patient was treated with PREDNISOLONE (10 Mg, Daily (1/d)) (View Prednisolone Review and Prednisolone Label ), COTRIM (1 D/f, Daily (1/d)) (View Cotrim Review and Cotrim Label ), OMEPRAL (20 Mg, Daily (1/d)) (View Omepral Review and Omepral Label ), AMLODIPINE (5 Mg, Daily (1/d)) (View Amlodipine Review and Amlodipine Label ), BENET /JPN/ (17.5 Mg, Daily (1/d)) (View Benet /jpn/ Review and Benet /jpn/ Label ), MEDICON (90 Mg, Daily (1/d)) (View Medicon Review and Medicon Label ), CYCLOSPORINE (100 Mg, Daily (1/d)) (View Cyclosporine Review and Cyclosporine Label ), ITRIZOLE (20 Ml, Daily (1/d)) (View Itrizole Review and Itrizole Label ).

6698271-4 | Dyspnoea Exertional
on Apr 15, 2010 Female patient from JAPAN , 67 years of age, weighting 97.89 lb, was diagnosed with pulmonary arterial hypertension, scleroderma (What is scleroderma?), prophylaxis and was treated with Tadalafil (View Usage). Patient had the following side effects: dyspnoea exertional. Tadalafil dosage: 40 Mg, Daily (1/d). During the same period patient was treated with JUVELA N (300 Mg, Daily (1/d)) (View Juvela N Review and Juvela N Label ), ASPIRIN (100 Mg, Daily (1/d)) (View Aspirin Review and Aspirin Label ), TRACLEER (187.5 Mg, Daily (1/d)) (View Tracleer Review and Tracleer Label ), ALINAMIN F (75 Mg, Daily (1/d)) (View Alinamin F Review and Alinamin F Label ), METHYCOBAL (1500 Ug, Daily (1/d)) (View Methycobal Review and Methycobal Label ), ONEALFA (0.5 Ug, Daily (1/d)) (View Onealfa Review and Onealfa Label ), MAGMITT (500 Mg, Daily (1/d)) (View Magmitt Review and Magmitt Label ), LAC B (3 G, Daily (1/d)) (View Lac B Review and Lac B Label ). Patient was hospitalized.

6687803-8 | Hospitalisation
Patient was taking Tadalafil (View Usage). After Tadalafil was administered, patient had the following side effects: hospitalisation on Apr 15, 2010 from JAPAN Additional patient health information: Male patient , 64 years of age, . Tadalafil dosage: 40 Mg, Daily (1/d). Patient was hospitalized.

6642477-7 | Dyspnoea Exertional
Adverse event was reported on Mar 09, 2010 by a Female patient taking Tadalafil (View Usage) (Dosage: 40 Mg, Daily (1/d)) was diagnosed with pulmonary arterial hypertension, scleroderma (What is scleroderma?), prophylaxis and. Location: JAPAN , 67 years of age, weighting 97.89 lb, Patient experienced the following unwanted or unexpected effects: dyspnoea exertional. During the same period patient was treated with JUVELA N (300 Mg, Daily (1/d)) (View Juvela N Review and Juvela N Label ), ASPIRIN (100 Mg, Daily (1/d)) (View Aspirin Review and Aspirin Label ), TRACLEER (187.5 Mg, Daily (1/d)) (View Tracleer Review and Tracleer Label ), ALINAMIN F (75 Mg, Daily (1/d)) (View Alinamin F Review and Alinamin F Label ), METHYCOBAL (1500 Ug, Daily (1/d)) (View Methycobal Review and Methycobal Label ), ONEALFA (0.5 Ug, Daily (1/d)) (View Onealfa Review and Onealfa Label ), MAGMITT (500 Mg, Daily (1/d)) (View Magmitt Review and Magmitt Label ), LAC B (3 G, Daily (1/d)) (View Lac B Review and Lac B Label ). Patient was hospitalized.

6640882-6 | Dizziness, Headache, Intentional Overdose, Suicide Attempt
on Mar 05, 2010 Male patient from AUSTRIA , 30 years of age, was treated with Tadalafil (View Usage). Patient had the following side effects: dizziness (What is dizziness?), headache (What is headache?), intentional overdose, suicide attempt. Tadalafil dosage: . Patient was hospitalized.

6599175-8 | Cardiac Failure, Muscle Haemorrhage
on Feb 16, 2010 Male patient from GERMANY , weighting 273.4 lb, was diagnosed with pulmonary arterial hypertension and was treated with Tadalafil (View Usage). After Tadalafil was administered, patient had the following side effects: cardiac failure, muscle haemorrhage. Tadalafil dosage: 40 Mg, Daily (1/d). During the same period patient was treated with HEPARIN (View Heparin Review and Heparin Label ), INSPRA (View Inspra Review and Inspra Label ), DIOVAN (View Diovan Review and Diovan Label ), ALLOPURINOL (View Allopurinol Review and Allopurinol Label ), KALINOR (View Kalinor Review and Kalinor Label ), SITAXSENTAN (View Sitaxsentan Review and Sitaxsentan Label ), TOREM (View Torem Review and Torem Label ), VENTAVIS (View Ventavis Review and Ventavis Label ). Patient was hospitalized.

6574661-5 | Prostatitis
Patient was taking Tadalafil (View Usage). Patient experienced the following unwanted or unexpected effects: prostatitis on Jan 27, 2010 from FRANCE Additional patient health information: Male patient , weighting 176.4 lb, was diagnosed with benign prostatic hyperplasia, pyrexia and. Tadalafil dosage: 2.5 Mg, Daily (1/d). During the same period patient was treated with DOLIPRANE (View Doliprane Review and Doliprane Label ). Patient was hospitalized.

6542063-3 | Bladder Disorder, Prostate Cancer
Adverse event was reported on Jan 08, 2010 by a Male patient taking Tadalafil (View Usage) (Dosage: 10 Mg, As Needed) . Location: UNITED KINGDOM , 78 years of age, Patient had the following side effects: bladder disorder, prostate cancer (What is prostate cancer?).

6531085-4 | Glaucoma
on Nov 16, 2009 Male patient from JAPAN , weighting 138.9 lb, was diagnosed with erectile dysfunction (What is erectile dysfunction?), glaucoma (What is glaucoma?) and was treated with Tadalafil (View Usage). After Tadalafil was administered, patient had the following side effects: glaucoma (What is glaucoma?). Tadalafil dosage: 20 Mg, As Needed. During the same period patient was treated with DIAMOX /00016901/ (500 Mg, Daily (1/d)) (View Diamox /00016901/ Review and Diamox /00016901/ Label ), GLUCONSAN K (10 Meq, Daily (1/d)) (View Gluconsan K Review and Gluconsan K Label ). Patient was hospitalized.

6504217-1 | Prostatitis
on Dec 08, 2009 Male patient from FRANCE , weighting 176.4 lb, was diagnosed with benign prostatic hyperplasia, pyrexia and was treated with Tadalafil (View Usage). Patient experienced the following unwanted or unexpected effects: prostatitis. Tadalafil dosage: 2.5 Mg, Daily (1/d). During the same period patient was treated with DOLIPRANE (View Doliprane Review and Doliprane Label ). Patient was hospitalized.

6483841-9 | Glaucoma
Patient was taking Tadalafil (View Usage). Patient had the following side effects: glaucoma (What is glaucoma?) on Nov 27, 2009 from JAPAN Additional patient health information: Male patient , weighting 138.9 lb, was diagnosed with erectile dysfunction (What is erectile dysfunction?), glaucoma (What is glaucoma?) and. Tadalafil dosage: 20 Mg, As Needed. During the same period patient was treated with DIAMOX /00016901/ (500 Mg, Daily (1/d)) (View Diamox /00016901/ Review and Diamox /00016901/ Label ), GLUCONSAN K (10 Meq, Daily (1/d)) (View Gluconsan K Review and Gluconsan K Label ). Patient was hospitalized.

6478585-3 | Cardiac Failure, Intentional Overdose
Adverse event was reported on Nov 26, 2009 by a Male patient taking Tadalafil (View Usage) (Dosage: ) . Location: TRINIDAD AND TOBAGO , 72 years of age, After Tadalafil was administered, patient had the following side effects: cardiac failure, intentional overdose.

6475318-1 | Dyspepsia, Facial Palsy, Headache, Hot Flush, Intraocular Pressure Increased, Musculoskeletal Stiffness, Visual Impairment, Vomiting
on Apr 08, 2009 Male patient from KOREA, REPUBLIC OF , 56 years of age, was diagnosed with erectile dysfunction (What is erectile dysfunction?), benign prostatic hyperplasia and was treated with Tadalafil (View Usage). Patient experienced the following unwanted or unexpected effects: dyspepsia, facial palsy, headache (What is headache?), hot flush, intraocular pressure increased, musculoskeletal stiffness, visual impairment, vomiting. Tadalafil dosage: 5 Mg, Daily (1/d). During the same period patient was treated with TAMSULOSIN (View Tamsulosin Review and Tamsulosin Label ).

6474658-X | Cardiac Failure Congestive, Fall, Mitral Valve Incompetence, Syncope
on May 27, 2009 Female patient from UNITED STATES , weighting 146.0 lb, was diagnosed with pulmonary arterial hypertension, herpes zoster, hypokalaemia, hypercholesterolaemia, depression (What is depression?) and was treated with Tadalafil (View Usage). Patient had the following side effects: cardiac failure congestive, fall (What is fall?), mitral valve incompetence, syncope. Tadalafil dosage: Unk, Daily (1/d). During the same period patient was treated with VICODIN (View Vicodin Review and Vicodin Label ), POTASSIUM CHLORIDE (View Potassium Chloride Review and Potassium Chloride Label ), FUROSEMIDE (View Furosemide Review and Furosemide Label ), DIGOXIN (View Digoxin Review and Digoxin Label ), ATENOLOL (View Atenolol Review and Atenolol Label ), LIPITOR (View Lipitor Review and Lipitor Label ), FLUOXETINE HYDROCHLORIDE (View Fluoxetine Hydrochloride Review and Fluoxetine Hydrochloride Label ). Patient was hospitalized.

6471262-4 | Erythema, Heart Rate Increased, Intraocular Pressure Test, Ocular Hyperaemia
Patient was taking Tadalafil (View Usage). After Tadalafil was administered, patient had the following side effects: erythema, heart rate increased, intraocular pressure test, ocular hyperaemia on Feb 20, 2008 from GERMANY Additional patient health information: Male patient , 41 years of age, was diagnosed with erectile dysfunction (What is erectile dysfunction?), type 2 diabetes mellitus and. Tadalafil dosage: 20 Mg, Unk. During the same period patient was treated with INSULIN (View Insulin Review and Insulin Label ).

6469176-9 | Histiocytosis Haematophagic
Adverse event was reported on Oct 23, 2007 by a Female patient taking Tadalafil (View Usage) (Dosage: 20 Mg, Each Morning) was diagnosed with pulmonary arterial hypertension, pulmonary hypertension (What is pulmonary hypertension?), gastritis prophylaxis, osteoporosis (What is osteoporosis?), infection prophylaxis, hyperlipidaemia, systemic lupus erythematosus and. Location: JAPAN , weighting 126.5 lb, Patient experienced the following unwanted or unexpected effects: histiocytosis haematophagic. During the same period patient was treated with PROCYLIN (160 Ug, Daily (1/d)) (View Procylin Review and Procylin Label ), SELBEX (150 Mg, Daily (1/d)) (View Selbex Review and Selbex Label ), WARFARIN SODIUM (4.5 Mg, Daily (1/d)) (View Warfarin Sodium Review and Warfarin Sodium Label ), ONEALFA (1 Ug, Daily (1/d)) (View Onealfa Review and Onealfa Label ), BAKTAR (1 D/f, Daily (1/d)) (View Baktar Review and Baktar Label ), MEVALOTIN /JPN/ (10 Mg, Daily (1/d)) (View Mevalotin /jpn/ Review and Mevalotin /jpn/ Label ), BONALON (5 Mg, Daily (1/d)) (View Bonalon Review and Bonalon Label ), PREDONINE (10 Mg, Daily (1/d)) (View Predonine Review and Predonine Label ).

6469118-6 | Dystonia
on Nov 08, 2007 Female patient from UNITED STATES , weighting 151.0 lb, was diagnosed with pulmonary arterial hypertension, sedation, anaemia and was treated with Tadalafil (View Usage). Patient had the following side effects: dystonia (What is dystonia?). Tadalafil dosage: 40 Mg, Unk. During the same period patient was treated with PROPOFOL (View Propofol Review and Propofol Label ), FENTANYL (View Fentanyl Review and Fentanyl Label ), MIDAZOLAM HCL (View Midazolam Hcl Review and Midazolam Hcl Label ), ZOFRAN (View Zofran Review and Zofran Label ), KETOROLAC TROMETHAMINE (View Ketorolac Tromethamine Review and Ketorolac Tromethamine Label ), DIOVAN /SCH/ (View Diovan /sch/ Review and Diovan /sch/ Label ), HYDROCHLOROTHIAZIDE (View Hydrochlorothiazide Review and Hydrochlorothiazide Label ), IRON (View Iron Review and Iron Label ). Patient was hospitalized.

6469101-0 | Breast Cancer Recurrent
on Jan 19, 2009 Female patient from JAPAN , weighting 127.9 lb, was diagnosed with pulmonary arterial hypertension, collagen disorder, hypokalaemia, cardiac failure, prophylaxis, pulmonary fibrosis (What is pulmonary fibrosis?), hyperuricaemia and was treated with Tadalafil (View Usage). After Tadalafil was administered, patient had the following side effects: breast cancer recurrent. Tadalafil dosage: 40 Mg, Daily (1/d). During the same period patient was treated with PREDONINE (5 Mg, Daily (1/d)) (View Predonine Review and Predonine Label ), ASPARA K (900 Mg, 3/d) (View Aspara K Review and Aspara K Label ), DIART (60 Mg, Daily (1/d)) (View Diart Review and Diart Label ), MAINTATE (5 Mg, Daily (1/d)) (View Maintate Review and Maintate Label ), DORNER (160 Ug, 4/d) (View Dorner Review and Dorner Label ), ARIMIDEX (1 Mg, Daily (1/d)) (View Arimidex Review and Arimidex Label ), MUCOSOLATE (45 Mg, 3/d) (View Mucosolate Review and Mucosolate Label ), ALLOZYM (100 Mg, Daily (1/d)) (View Allozym Review and Allozym Label ). Patient was hospitalized.

6456274-9 | Glaucoma
Patient was taking Tadalafil (View Usage). Patient experienced the following unwanted or unexpected effects: glaucoma (What is glaucoma?) on Nov 16, 2009 from JAPAN Additional patient health information: Male patient , weighting 138.9 lb, was diagnosed with erectile dysfunction (What is erectile dysfunction?), glaucoma (What is glaucoma?) and. Tadalafil dosage: 20 Mg, As Needed. During the same period patient was treated with DIAMOX /00016901/ (500 Mg, Daily (1/d)) (View Diamox /00016901/ Review and Diamox /00016901/ Label ), GLUCONSAN K (10 Meq, Daily (1/d)) (View Gluconsan K Review and Gluconsan K Label ). Patient was hospitalized.

6453328-8 | Vision Blurred
Adverse event was reported on Nov 11, 2009 by a Male patient taking Tadalafil (View Usage) (Dosage: ) was diagnosed with erectile dysfunction (What is erectile dysfunction?) and. Location: COSTA RICA , 35 years of age, Patient had the following side effects: vision blurred.

6421741-0 | Vision Blurred
on Oct 20, 2009 Male patient from COSTA RICA , 35 years of age, was diagnosed with erectile dysfunction (What is erectile dysfunction?) and was treated with Tadalafil (View Usage). After Tadalafil was administered, patient had the following side effects: vision blurred. Tadalafil dosage: .

6412557-X | Oesophageal Achalasia
on Oct 15, 2009 Female patient from UNITED STATES , weighting 149.0 lb, was diagnosed with pulmonary arterial hypertension, anaemia, hypothyroidism, constipation (What is constipation?), reflux oesophagitis and was treated with Tadalafil (View Usage). Patient experienced the following unwanted or unexpected effects: oesophageal achalasia. Tadalafil dosage: Unk, Daily (1/d). During the same period patient was treated with REMODULIN (20 Mg/kg, Unk) (View Remodulin Review and Remodulin Label ), WARFARIN SODIUM (2 Mg, Unk) (View Warfarin Sodium Review and Warfarin Sodium Label ), FERROUS SULFATE TAB (325 Mg, 3/d) (View Ferrous Sulfate Tab Review and Ferrous Sulfate Tab Label ), LEVOTHYROXINE SODIUM (100 Ug, Daily (1/d)) (View Levothyroxine Sodium Review and Levothyroxine Sodium Label ), SENNA (Unk, As Needed) (View Senna Review and Senna Label ), NEXIUM (Unk, Unk) (View Nexium Review and Nexium Label ). Patient was hospitalized.

6406956-X | Chest Pain, Shock, Therapeutic Response Decreased
Patient was taking Tadalafil (View Usage). Patient had the following side effects: chest pain (What is chest pain?), shock, therapeutic response decreased on Oct 12, 2009 from TRINIDAD AND TOBAGO Additional patient health information: Male patient , 35 years of age, . Tadalafil dosage: .

6379650-1 | Oesophageal Achalasia
Adverse event was reported on Sep 16, 2009 by a Female patient taking Tadalafil (View Usage) (Dosage: Unk, Daily (1/d)) was diagnosed with pulmonary arterial hypertension, anaemia, hypothyroidism, constipation (What is constipation?), reflux oesophagitis and. Location: UNITED STATES , weighting 149.0 lb, After Tadalafil was administered, patient had the following side effects: oesophageal achalasia. During the same period patient was treated with REMODULIN (20 Mg/kg, Unk) (View Remodulin Review and Remodulin Label ), WARFARIN (2 Mg, Unk) (View Warfarin Review and Warfarin Label ), FERROUS SULFATE TAB (325 Mg, 3/d) (View Ferrous Sulfate Tab Review and Ferrous Sulfate Tab Label ), LEVOTHYROXINE SODIUM (100 Ug, Daily (1/d)) (View Levothyroxine Sodium Review and Levothyroxine Sodium Label ), SENNA (Unk, As Needed) (View Senna Review and Senna Label ), NEXIUM (Unk, Unk) (View Nexium Review and Nexium Label ). Patient was hospitalized.

6368266-9 | Fall, Head Injury
on Sep 11, 2009 Male patient from BRAZIL , 66 years of age, was diagnosed with erectile dysfunction (What is erectile dysfunction?) and was treated with Tadalafil (View Usage). Patient experienced the following unwanted or unexpected effects: fall (What is fall?), head injury. Tadalafil dosage: .

6325990-1 | Oesophageal Achalasia
on Aug 12, 2009 Female patient from UNITED STATES , weighting 149.0 lb, was diagnosed with pulmonary arterial hypertension, anaemia, hypothyroidism, constipation (What is constipation?), reflux oesophagitis, anxiety (What is anxiety?) and was treated with Tadalafil (View Usage). Patient had the following side effects: oesophageal achalasia. Tadalafil dosage: Unk, Daily (1/d). During the same period patient was treated with REMODULIN (20 Mg/kg, Unk) (View Remodulin Review and Remodulin Label ), WARFARIN (2 Mg, Unk) (View Warfarin Review and Warfarin Label ), FERROUS SULFATE TAB (325 Mg, 3/d) (View Ferrous Sulfate Tab Review and Ferrous Sulfate Tab Label ), LEVOTHYROXINE SODIUM (100 Ug, Daily (1/d)) (View Levothyroxine Sodium Review and Levothyroxine Sodium Label ), SENNA (Unk, As Needed) (View Senna Review and Senna Label ), NEXIUM (Unk, Unk) (View Nexium Review and Nexium Label ), KLONOPIN (0.5 Mg, Daily (1/d)) (View Klonopin Review and Klonopin Label ). Patient was hospitalized.

6291659-5 | Phimosis
Patient was taking Tadalafil (View Usage). After Tadalafil was administered, patient had the following side effects: phimosis on Jul 20, 2009 from GUATEMALA Additional patient health information: Male patient , 45 years of age, was diagnosed with erectile dysfunction (What is erectile dysfunction?) and. Tadalafil dosage: 20 Mg, As Needed. Patient was hospitalized.

6288512-X | Oesophageal Achalasia
Adverse event was reported on Jul 17, 2009 by a Female patient taking Tadalafil (View Usage) (Dosage: 40 Mg, Daily (1/d)) was diagnosed with pulmonary arterial hypertension, anaemia, hypothyroidism, constipation (What is constipation?), reflux oesophagitis, anxiety (What is anxiety?), insomnia and. Location: UNITED STATES , weighting 149.0 lb, Patient experienced the following unwanted or unexpected effects: oesophageal achalasia. During the same period patient was treated with REMODULIN (20 Mg/kg, Unk) (View Remodulin Review and Remodulin Label ), WARFARIN SODIUM (2 Mg, Unk) (View Warfarin Sodium Review and Warfarin Sodium Label ), FERROUS SULFATE TAB (325 Mg, 3/d) (View Ferrous Sulfate Tab Review and Ferrous Sulfate Tab Label ), LEVOTHYROXINE SODIUM (100 Ug, Daily (1/d)) (View Levothyroxine Sodium Review and Levothyroxine Sodium Label ), SENNA (Unk, As Needed) (View Senna Review and Senna Label ), NEXIUM (Unk, Unk) (View Nexium Review and Nexium Label ), KLONOPIN (0.5 Mg, Daily (1/d)) (View Klonopin Review and Klonopin Label ), LUNESTA (2 Mg, As Needed) (View Lunesta Review and Lunesta Label ). Patient was hospitalized.

6269722-4 | Pulmonary Hypertension
on Jul 09, 2009 Male patient from NETHERLANDS ANTILLES , 50 years of age, was diagnosed with erectile dysfunction (What is erectile dysfunction?) and was treated with Tadalafil (View Usage). Patient had the following side effects: pulmonary hypertension (What is pulmonary hypertension?). Tadalafil dosage: 20 Mg, 2/w.

6252750-2 | Oesophageal Achalasia
on Jun 18, 2009 Female patient from UNITED STATES , weighting 149.0 lb, was diagnosed with pulmonary arterial hypertension, anaemia, hypothyroidism, constipation (What is constipation?), reflux oesophagitis, anxiety (What is anxiety?), insomnia and was treated with Tadalafil (View Usage). After Tadalafil was administered, patient had the following side effects: oesophageal achalasia. Tadalafil dosage: 40 Mg, Daily (1/d). During the same period patient was treated with REMODULIN (20 Mg/kg, Unk) (View Remodulin Review and Remodulin Label ), WARFARIN (2 Mg, Unk) (View Warfarin Review and Warfarin Label ), FERROUS SULFATE TAB (325 Mg, 3/d) (View Ferrous Sulfate Tab Review and Ferrous Sulfate Tab Label ), LEVOTHYROXINE SODIUM (100 Ug, Daily (1/d)) (View Levothyroxine Sodium Review and Levothyroxine Sodium Label ), SENNA (Unk, As Needed) (View Senna Review and Senna Label ), NEXIUM (Unk, Unk) (View Nexium Review and Nexium Label ), KLONOPIN (0.5 Mg, Daily (1/d)) (View Klonopin Review and Klonopin Label ), LUNESTA (2 Mg, As Needed) (View Lunesta Review and Lunesta Label ). Patient was hospitalized.

6220404-4 | Cardiac Failure Congestive, Fall, Mitral Valve Incompetence, Syncope
Patient was taking Tadalafil (View Usage). Patient experienced the following unwanted or unexpected effects: cardiac failure congestive, fall (What is fall?), mitral valve incompetence, syncope on May 27, 2009 from UNITED STATES Additional patient health information: Female patient , weighting 146.0 lb, was diagnosed with pulmonary arterial hypertension, herpes zoster, hypokalaemia, hypercholesterolaemia, depression (What is depression?) and. Tadalafil dosage: Unk, Daily (1/d). During the same period patient was treated with VICODIN (View Vicodin Review and Vicodin Label ), POTASSIUM CHLORIDE (View Potassium Chloride Review and Potassium Chloride Label ), FUROSEMIDE (View Furosemide Review and Furosemide Label ), DIGOXIN (View Digoxin Review and Digoxin Label ), ATENOLOL (View Atenolol Review and Atenolol Label ), LIPITOR (View Lipitor Review and Lipitor Label ), FLUOXETINE HYDROCHLORIDE (View Fluoxetine Hydrochloride Review and Fluoxetine Hydrochloride Label ). Patient was hospitalized.

6198011-1 | Rhinitis
Adverse event was reported on May 12, 2009 by a Male patient taking Tadalafil (View Usage) (Dosage: ) was diagnosed with erectile dysfunction (What is erectile dysfunction?) and. Location: LEBANON , 54 years of age, Patient had the following side effects: rhinitis.

6167923-7 | Aortic Calcification, Aortic Stenosis, Arteriosclerosis, Blood Glucose Increased, Cardiac Failure Congestive, Fall, Haemoglobin Decreased, International Normalised Ratio Increased, Intervertebral Disc Disorder
on Apr 14, 2009 Female patient from UNITED STATES , weighting 146.0 lb, was diagnosed with pulmonary arterial hypertension, herpes zoster, hypokalaemia, hypercholesterolaemia, depression (What is depression?) and was treated with Tadalafil (View Usage). After Tadalafil was administered, patient had the following side effects: aortic calcification, aortic stenosis, arteriosclerosis, blood glucose increased, cardiac failure congestive, fall (What is fall?), haemoglobin decreased, international normalised ratio increased, intervertebral disc disorder. Tadalafil dosage: Unk, Daily (1/d). During the same period patient was treated with VICODIN (View Vicodin Review and Vicodin Label ), POTASSIUM CHLORIDE (View Potassium Chloride Review and Potassium Chloride Label ), FUROSEMIDE (View Furosemide Review and Furosemide Label ), DIGOXIN (View Digoxin Review and Digoxin Label ), ATENOLOL (View Atenolol Review and Atenolol Label ), LIPITOR (View Lipitor Review and Lipitor Label ), FLUOXETINE HYDROCHLORIDE (View Fluoxetine Hydrochloride Review and Fluoxetine Hydrochloride Label ). Patient was hospitalized.

6160381-8 | Dyspepsia, Facial Palsy, Headache, Hot Flush, Intraocular Pressure Increased, Musculoskeletal Stiffness, Visual Impairment, Vomiting
on Apr 08, 2009 Male patient from KOREA, REPUBLIC OF , 56 years of age, was diagnosed with erectile dysfunction (What is erectile dysfunction?), benign prostatic hyperplasia and was treated with Tadalafil (View Usage). Patient experienced the following unwanted or unexpected effects: dyspepsia, facial palsy, headache (What is headache?), hot flush, intraocular pressure increased, musculoskeletal stiffness, visual impairment, vomiting. Tadalafil dosage: 5 Mg, Daily (1/d). During the same period patient was treated with TAMSULOSIN HCL (View Tamsulosin Hcl Review and Tamsulosin Hcl Label ).

6154486-5 | Rhinitis
Patient was taking Tadalafil (View Usage). Patient had the following side effects: rhinitis on Apr 06, 2009 from LEBANON Additional patient health information: Male patient , 54 years of age, was diagnosed with erectile dysfunction (What is erectile dysfunction?) and. Tadalafil dosage: .